Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Urinary Bladder Neoplasms 17Colorectal Neoplasms 17Non-Muscle Invasive Bladder Neoplasms 10Neoplasm Metastasis 10Stomach Neoplasms 9Appendiceal Neoplasms 9Anus Neoplasms 9Peritoneal Neoplasms 8Carcinoma, Hepatocellular 8Pancreatic Neoplasms 5Liver Neoplasms 4Colonic Neoplasms 4Pseudomyxoma Peritonei 3Carcinoma, Transitional Cell 3Carcinoma, Non-Small-Cell Lung 3Uterine Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rectal Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Urothelial Carcinoma Ureter 1Urethral Neoplasms 1Ureteral Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Cyclophosphamide 254fludarabine phosphate 165Cytarabine 160Methotrexate 128Busulfan 115Filgrastim 111fludarabine 102Peripheral Blood Stem Cell Transplantation 96Rituximab 94Antilymphocyte Serum 83Etoposide 81Cyclosporine 75Tacrolimus 74Mycophenolic Acid 73Whole-Body Irradiation 72Radiotherapy 70Melphalan 66Vincristine 55Dexamethasone 54Granulocyte Colony-Stimulating Factor 50Methylprednisolone 48Azacitidine 44Alemtuzumab 42Imatinib Mesylate 41Clofarabine 41sargramostim 40Idarubicin 36Daunorubicin 36Cord Blood Stem Cell Transplantation 36Mercaptopurine 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia × Mitomycin × Clear all
NCT00003003 2018-03-19

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
29 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡